Diaxxo raises €46K Pre-Seed round
1 January 2020· Zurich, Switzerland· health, biotech, diagnostics, point_of_care, software_hardware, b2b
To develop and prototype an innovative Point-of-Care Polymerase Chain Reaction (PCR) device and enable DNA analyses to be widely diffused and adopted by making them accurate and affordable.
Investors
LeadETH Zurich
Also participating
Venture Kick
About Diaxxo
Stage
Pre-Seed
Headquarters
Zurich, Switzerland
Founded
2020
Team Size
6–20
Sectors
healthbiotechdiagnosticspoint_of_caresoftware_hardwareb2b